Related Experiment Video
Updated: Jun 5, 2026
14:25
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
Counterpoint: chemosensitivity assays for recurrent ovarian cancer
1Cancer Treatment Centers of America, Philadelphia, Pennsylvania 19124, USA. maurie.markman@ctca-hope.com
Journal of the National Comprehensive Cancer Network : JNCCN
|January 15, 2011
Abstract:
Unfortunately, no reliable evidence-based data have shown any in vitro chemosensitivity assay strategy to be clinically useful in the management of recurrent ovarian cancer, despite frequent use. Several clinical trials have been proposed with the potential to support or refute the relevance of these approaches.
